Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation-Reference-Cited by-同舟云学术

Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation

Published:2021-02-22 Issue:3 Volume:105 Page:648-659
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Irish William,Nickerson Peter,Astor Brad C.,Chong Edward,Wiebe Chris,Moreso Francesc,Seron Daniel,Crespo Marta,Gache Larry,Djamali Arjang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. Long-term renal allograft survival in the United States: a critical reappraisal.;Lamb;Am J Transplant,2011

2. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.;Sellarés;Am J Transplant,2012

3. Identifying specific causes of kidney allograft loss.;El-Zoghby;Am J Transplant,2009

4. The Banff 2017 Kidney Meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.;Haas;Am J Transplant,2018

5. Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.;Reeve;JCI Insight,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Rejection After Kidney Transplantation;Transplantation;2024-08-28

2. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection;New England Journal of Medicine;2024-07-11

3. Challenges and opportunities for designing clinical trials for antibody mediated rejection;Frontiers in Transplantation;2024-06-12

4. Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study);Trials;2024-03-22

5. Translating B cell immunology to the treatment of antibody-mediated allograft rejection;Nature Reviews Nephrology;2024-01-02